A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction

NCT07304843 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Biliary Cholangitis (PBC)

Interventions

DRUG: golexanolone
DRUG: golexanolone
DRUG: Placebo
DRUG: golexanolone
DRUG: Placebo

Sponsor

Umecrine Cognition AB